Market Research Blog – Page 14039 – New Product Development

Global Inspection Machines Market Comprehensive Shares, Historical Trends And Forecast By 2026

These solutions are not only expanding its footprint in manufacturing sectors, but also growing its demand in non- manufacturing applications. Inspection Machines are a types of machines which are used in scrutinizing products specially, packaging components or packages in order to ensure the specifications. Evolving technologies have also increased the inspection tasks which can be easily performed.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-2132

For instance, earlier the metal detectors were limited to detect ferrous metals but nowadays, with the help of different technology, it is possible to detect wood, glass, bone and also non-ferrous metals in products. The inspection systems has a wide application in the pharmaceutical industry in order to check the batch codes and to check that every component of packaging is precise for the product being packed or not. However, this million dollar industry is anticipated to witness strong growth worldwide during the forecast period, 2016-2026.

Inspection Machine Market: Market Dynamics

Rising number of inspection checkpoints along with growing adoption of automated inspection machines is expected to fuel the inspection machines market. One of the major factor which is driving the inspection machines market is the increasing number of governing obligations in order to maintain the agreement with the Good Manufacturing Practices (GMP). However, increase in demand for reused or refurbished machines is expected to make a major hindrance to the inspection machines market and also affect the new machinery sales inspection machines.

Inspection Machine Market: Region-wise outlook

Inspection Machine Market has been segmented into five different regions which includes North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Among these all the regions, North America is expected to account for the largest market share of the inspection machines market followed by Europe in terms of sales consumption which in turn dominate the market throughout the forecast period. The market is highly consolidated in United States (U.S.). Though, Asia Pacific lags behind in terms of total market size as compared to North America and Europe, the market in Asia Pacific is gaining eminence in countries like China and India. Henceforth, the inspection machine market is expected to witness significant growth in Europe and North America.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-2132

Inspection Machine Market: Key Pl ayers

Some of the key participants of inspection machine market includes Brevetti C.E.A. Spa, Bosch Packaging Technology, Iris Inspection Machines, CMP PHAR.MA S.R.L., A.H. Industries, Tofflon Science and Technology Co.Ltd, Proditec Automatic Inspection Machines, ANTARES VISION S.r.l., Brevetti C.E.A. SPA, Mettler-Toledo International Inc., Cognex Corporation, Körber Medipak Systems AG, Korber AG and many others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geography, technology, and applications.

The Report covers exhaust Analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends /Issues/Challenges
Competition & Companies involved
Technology

Regional Analysis includes:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

The report is a compilation of first-hand information, qualitative, and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-2132

Inspection Machines Market

inspection machine market is broadly classified on the basis of equipment types, forms of inspection machines, packaging type and end-use applications

On the basis of packaging type, the global inspection machines market is segmented into

blisters
ampoules
syringes
vials
others

On the basis of end-use, the global inspection machines market is segmented into

pharmaceuticals
medical devices
Others

On the basis of machines, the global inspection machines market is segmented into

color sorters
checkweighers
metal detectors

CMO/CDMO Market is expected to grow rapidly in the next 5-10 years

An increasing number of companies within the pharmaceutical sector have been considering contract manufacturing in response to the increasing demand for generic drugs and biologics. In a new study, Future Market Insights (FMI) has forecast the global contract manufacturing/ contract development and manufacturing organization (CMO/ CDMO) market to surpass US$ 18 Bn by 2020.

According to the study, contract manufacturing accounts for 3/4^th of all the CMO and CDMO services. Focus towards cost management, enhanced process flow, and better scalability will drive the market over the forecast period. Besides this, the increasing demand for skin care products, which also accounts for the leading share in terms of product type, will enable the market gain impetus in the coming years.

Key Takeaways from CMO/CDMOs Market Study

CMO/ CDMO services has become highly sought-after in pharmaceutical and beauty industries. FMI has projected the market to report 6.2% CAGR between 2020 and 2030
The U.S. is expected to account for over 77% of sales in North America by 2030
The U.K. will represent impressive scope for expansion, exhibiting above 7% CAGR through the forecast period
The rising focus on healthcare and wellness spending will support growth in Germany and France
The availability of inexpensive labor and resources will continue supporting growth in China. However, Japan and South Korea markets are expected to register higher percentage of growth over the forecast period

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-13038

In terms of the effect of COVID-19 pandemic on the demand of CMO/CDMO services, there was a negative impact on the market growth. One of the major issues was related to the supply chain gap. Prior to COVID-19, contract manufacturing was one of the most preferred sectors in the growing beauty and personal care industry. However, due to the pandemic, the industry suffered major setbacks as expected product launches were delayed. A shift was observed in consumer habits. Reduction of sales of leading products was recorded along with production slowdowns, which caused overhead to curb the profitability.

Who is Winning?

Collaboration is the key strategy amongst market players. The CMO/CDMO companies continue to focus on collaborations to gain sustainability in the market.

For instance, In February 2021, Lonza signed an agreement to divest its specialty ingredients business to Bain Capital and Cinven, aiming to refocus as a pure-play partner to the healthcare industry.

In 2021, Pierre Fabre Group hosted a pioneering custom online partnering forum, partnering with biopharmaceutical firms aiming to accelerate the digital transformation of Pierre Fabre Group
In 2020, In March 2020, Pierre Fabre Group, in partnership with numerous hospitals in the Occitania region of France, donated hand care creams, body cleansing gels and thermal spring water sprays and hand sanitizers necessary to combat the spread of Covid-19.

Want more insights?

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-13038

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Cancer Diagnostics Market to grow at 8.5% CAGR through 2031

Rising prevalence of cancer is likely to fuel the demand for cancer diagnostics. A study by Future Market Insights (FMI) projects the cancer diagnostics market to surpass US$ 47.62 Bn in 2021. According to the World Health Organization (WHO), cancer is the second -leading cause of death globally, accounting for over 9.9 million deaths in 2020. Rising cases of cancer have been fuelling the demand for advanced diagnostics.

Technological advancements in various fields such as biopsy, imaging, biomarkers and endoscopy, rising prevalence of cancer, increase in government initiatives for creating awareness, rapidly increase in geriatric population, and growing government funding are key factors driving the growth of the cancer diagnostics market.

Timely detection of cancer requires suitable diagnostic tests to screen the immunosuppressed population which is at moderate risk of cancer, particularly for lung cancer, cervical cancer, breast cancer, prostate cancer, colon cancer and melanoma. Growing awareness of early signs and symptoms of cancer among physicians and other healthcare professionals as well as among the general population supplements the growth of cancer diagnostics.

Inclusion of cancer screening tests in National Cancer Screening Programs is another major factor expected to fuel the demand for cancer diagnostics. Introduction of regular mammography into national cancer programs by major developed countries where the incidence of breast cancer is high that is leading towards increasing adoption of cancer diagnostics in developed region.

For instance, the U.S. government has included the National Mammography Program in its national cancer screening programs. The government of Australia is taking initiative by conducting 3 cancer screening programs such as the National Cervical Screening Program, BreastScreen Australia and the National Bowel Cancer Screening Program. Similarly, most of the countries in Europe are continuously adopting HPV DNA screening for cervical cancer as a part of national cervical cancer programs.

Short-term Negative Impact Likely Due to COVID-19

The cancer diagnostics market is expected to experience short-term negative growth owing to a reduction in the cancer diagnosis procedures and adoption rate in developed and emerging countries. COVID-19 has impacted the landscape of cancer diagnostics. This has affected demand in various fronts, from prevention to screening and diagnosis, palliative care, treatment, and patient follow-up, to logistics and supplies of cancer diagnostic tests kits and other essential commodities.

Nonetheless after a period of muted growth, the market is poised to recover as economies return to normalcy. As per FMI, the rising incidence of lung cancer is attributable for over 19% of sales in the market.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1090

Key Takeaways from Cancer Diagnostics Market Study

The rising incidence of cancer will fuel the demand for cancer diagnostics, enabling the market register 8.5% CAGR between 2021 and 2022
Increasing cases of cancer in the U.S. accounts for 84% of demand in North America
Increasing healthcare spending will enable the U.K. market register over 5% y-o-y growth in 2021
Favorable reimbursement policies will support growth in France and Germany
Expansion of the healthcare sector will support growth in Japan and South Korea

Who is Winning?

Partnerships between cancer diagnostic assay kits developers, instrument manufacturers and technology licensers are often intended to increase the consumer base.

For instance, in March 2021, Illumina, Inc. signed a partnership agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits by using Illumina’s NextSeq 550Dx sequencing platform for cancer.

In June 2020, Thermo Fisher Scientific signed an agreement with Daiichi Sankyo to Co-launch a companion diagnostic for patients with non-small cell lung cancer for identifying Her2 gene mutations using the Oncomine Dx target test.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global cancer diagnostics market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the cancer diagnostics market on basis of the main test type in detail, cover every aspect of the market such as Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, CA Tests, HER2 Tests, BRCA Tests, ALK Tests, CEA Tests, EGFR Mutation Tests, KRAS Mutation Tests, Others), Imaging (Ultrasound, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others), Biopsy (Needle Biopsy, Endoscopic Biopsy, Bone Marrow Biopsy, Others), Liquid Biopsy, Immunohistochemistry and In Situ Hybridization, indication (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer and Others), and End-user (Hospital Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes and Others) across seven major regions.

For any queries linked with the report, ask an analyst >> https://www.futuremarketinsights.com/ask-question/rep-gb-1090

High Content Screening Market Will Escalate Rapidly in the Near Future

The increasing demand for cell visualization and quantification using advance technique has been enabling growth in the global high content market. As per a study by Future Market Insights (FMI), driven by rising application in pharmaceutical and biotech companies, the market is poised to reach a valuation of US$ 1.5 Bn by the end of 2021. As per the study, the pharmaceutical and the healthcare sector will account for over 31% of demand registered in the market in 2021.

High content screening is adopted for drug discovery and development. Increasing research in search of the novel drug candidate and target identification & validation is expected to propel the adoption of high content screening over the forecast years. Besides this, continuous focus on manufacturing high quality and technologically advanced cell imaging system is expected to accelerate demand over the course of the forecast period.

However, due to COVID 19 outbreak, the research and development activities were hampered immensely. This is expected to have a negative impact on the market. Nonetheless, increasing investments by key manufacturers in the development of advanced cell imaging product is expected to boost the market in the coming years.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-426

Key Takeaways of High Content Screening Market Study

The high content screening market will rise at register a little below 5% y-o-y growth in 2021, following a brief period of restrictions amid COVID-19
Presence of a sophisticated healthcare and pharmaceutical infrastructure is enabling the U.S. market account for over 90% of sales in North America
The U.K. will register an impressive 7.2% y-o-y growth in 2021 driven by increasing focus on research and development activities in the pharmaceutical sector
Demand registered in Germany and France is expected to rise significantly within Europe
Favorable government policies will support expansion in Japan, followed by China

Who is Winning?

The key manufacturers in the high content screening market are involved in several partnerships and collaboration to develop new cell imaging technology. The leading manufacturers are also making their business strategies by making collaborations with international laboratories and research institutes to develop new imaging technologies.

For instance, In December 2019, Leica Microsystems make a collaboration agreement with the European Molecular Biology Laboratory (EMBL) to develop new imaging technologies applicable in life science. With this agreement EMBL and Leica promoting new imaging technologies for cell imaging.

Valuable Insights into High Content Screening Market Study

Future Market Insights offers actionable insights and a unique perspective on the high content screening market in its latest study, presenting historical demand assessment from 2016 – 2020 and projections from 2021–2031 based on product (cell imaging & analysis, consumables, Softwares, services), industry (pharmaceutical & healthcare, biotechnology, educational institutions, independent CRO, government organizations and others), and by application (primary & secondary screening, target identification & validation, toxicity studies, compound profiling and others) in seven key regions.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-426

Hypoparathyroidism Treatment Market is projected to display a promising CAGR of approximately 8% through the end of the forecast period in 2031

Hypoparathyroidism is a rare endocrine disorder, which often results in levels of calcium and high levels of phosphate, which in turn results in the production of low or abnormal parathyroid (PTH) levels. According to a recent research report by Future Market Insights (FMI), the hypoparathyroidism treatment market is estimated to reach a valuation of US$ 717.7 Mn in 2021, and is projected to display a promising CAGR of approximately 8% through the end of the forecast period in 2031.

Hypothyroidism primarily arises from surgeries in the neck region. It is associated to accidental damage to the parathyroid gland. High prevalence of these surgeries is expected to boost the demand in the hypoparathyroidism treatment market. For instance, in the U.S., up to 115,000 people are diagnosed with the chronic hypoparathyroidism. The majority of the hypoparathyroidism cases are caused by anterior neck surgery, which accounts for up to 75% of the of all hypoparathyroidism cases. The remaining 25% cases are non-surgical or in very rare cases is linked to genetic disorders.

Furthermore, considering the rare occurrence of this medical condition, hypoparathyroidism has been designated as an orphan disease by the U.S. FDA and European Commission. This designation of orphan disease will help manufacturers to speed up their drug development processes, which leads to better availability of drugs for treatments of hypoparathyroidism.

However, the unprecedented nature of the COVID-19 pandemic has had a significant impact on the development of drugs for rare diseases including those associated with hypoparathyroidism. Preference now is being given to the development of life-savings drugs with greater focus on development of COVID-19 drugs and vaccines, thus halting or suspending existing clinical trials other than live saving drugs.

Also, this has led to the delay or postponement of enrolment of the new participants for clinical studies. Thus, the lack of sufficient data availability on the safety and effectiveness of treatments from clinical trials, will hurt short-term prospects. Clinical trials will gradually resume through 2021, and is anticipated to pick up pace during the forecast period.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7857

Key Takeaways from Hypoparathyroidism Treatment Marker Study

Calcium supplements dominate the hypoparathyroidism treatment market growing 2x by 2031 owing to efficacy with hormonal therapy.
Parenteral route of administration is projected to grow at higher pace, driven by a rise in the number of clinical trials, and approval of new drugs which are influencing strong growth in this segment.
United States holds over 85% of the North America market for hypoparathyroidism treatments and will remain dominant owing to government incentives.
The U.K. will exhibit high demand, registering y-o-y growth at nearly 7% in 2021.
Germany and France will emerge as key markets within Europe.
China and India reflect high potential for growth on the back of a large subclinical patient pool for kidney disorders, diabetes, obesity, thyroid surgeries or head & neck surgery.

Product Approvals, and Expansion Strategies Gain the Focus of Drug Manufacturers

Prominent players in the hypoparathyroidism treatment market are focusing on receiving approvals and grants for the development of new drugs to cater to the growing cases of hypoparathyroidism, thus, enhancing their market presence. For instance,

In October 2020, Ascendis’s TransCon PTH was designated as orphan drug by the European commission (EC), which is approved for use to treat hypoparathyroidism in Europe.
In July 2020, ProLynx, received a Small Business Innovation Research (SIBR) grant from NIH to help fasten the development PTH (1, 34), a long acting parathyroid hormone that can be in a week to patients suffering from hypoparathyroidism.

Key Participant Insights

Prominent players in the hypoparathyroidism treatment market is entering into the strategic agreements and collaborations at regional levels, with special focus on emerging economies. Major players are consolidating their positions through regional collaborations to strengthen their presence and increase their product reach in these countries.

Some of the leading market players covered by FMI in the hypoparathyroidism market include Takeda Pharmaceutical Company Limited., Entera Bio Ltd. Ascendis Pharma A/S, F. Hoffmann-La Roche Ltd, and BionPharma Inc.

Want more insights?

For any queries linked with the report, ask an analyst >> https://www.futuremarketinsights.com/ask-question/rep-gb-7857

DNA Polymerase Market to progress at a promising CAGR of over 6% through 2031

A growing number of drug patent expirations and the interest in generic biologics has gained significantly from developments in the DNA polymerase market. Rising demand for improvements in healthcare diagnostics are expected to remain key influencer in market growth. According to Future Market Insights, a new study has forecast the DNA polymerase market to exhibit a CAGR of approximately 6.5% during the forecast period from 2021 to 2031.

Major manufacturers in the DNA polymerase market are increasingly focused on investing in research and development efforts to widen the scope of applications in the sector. In addition, strategic acquisitions and collaborations to share expertise, leveraging biopharmaceuticals and contract manufacturing companies will find ground in the industry.

In terms of end users, molecular diagnostics companies are likely to remain primary contributors to the market accounting for more than 30% of the global market share. Furthermore, academic and research institutes will display a relatively faster rate of growth, driven by investments into R&D for accuracy in diagnostics, genome research, DNA cloning, and potential applications in cancer research.

Increasing R&D activities is a key factor positively influencing the development and use of high-fidelity DNA polymerase. Increasing incidences of cancer, concerns over uncontrolled genetic mutations, increasing awareness on neurological disorders, and potential for treating chronic diseases create lucrative opportunities in the DNA polymerase market. Also, the growing importance being given to personalized medicine will provide impetus to market players through the coming decade.

On the other hand, DNA polymerase market players are expected to face a number of challenges during the forecast period. For instance, shortage of adequately skilled professionals is a restraining factor affecting the market. Lack of information and awareness associated to DNA polymerase also affects sales prospects. Also, a shortage of funding by governments in the sector are restraining market growth. These factors are especially true in developing countries with restricted access to capital and infrastructure.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-801

Key Takeaways from DNA Polymerase Market Study

The global DNA polymerase market is projected to grow at approximately 6.5% CAGR through the projection period.
Molecular diagnostic applications will account for major market, with impetus from the covid-19 pandemic.
The U.S. will hold the lead in North America accounting for more than 50% of the global valuation.
China will reflect high growth potential accounting for a CAGR of over 7.5%, owing to rising healthcare spending.
UK will reflect high demand in Europe supported by the rise of contract research and manufacturing organizations in biopharmaceuticals.

Who is Winning?

The global DNA polymerase market is set to widen its scope of expansion through the assessment period, driven by a higher rate of adoption in molecular diagnostics, bioprocessing, cancer research and development of generic biologics in the biopharmaceutical sector. A shortage of adequately skilled professionals and lack of awareness has restrained revenue in the industry.

Some of the more prominent players in the DNA polymerase market include but are not limited to Thermo Fisher Scientific Inc., Hoffmann-La Roche AG, Merck KGaA, Qiagen N.V., Agilent Technologies Inc., Takara Bio Inc., Genescript, Illumina Inc., New England Biolabs, Inc., Bioline, and Promega Corporation.

Want More Insights?

Future Market Insights provides an exhaustive report in terms of forecast on global, regional, and country levels, with actionable insights on the latest industry trends in key segments from 2016 to 2031. The DNA polymerase market is segmented in detail to encompass all aspects, providing readers with a complete market intelligence report approach. The study provides details on the basis of product type (prokaryotic and eukaryotic), and end use (molecular diagnostics companies, diagnostic laboratories, academic and research institutes, biopharmaceutical companies, and hospitals), across seven major regions.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-801

Ready-to-Use Therapeutic Food Market 2022 | Latest Trends, Demand, Growth, Opportunities & Outlook Till 2030

Ready-to-use Therapeutic food market will grow at a steady CAGR through 2030, according to a new research by ESOMAR-certified firm Future Market Insights (FMI). The study opines that impact of COVID-19 on ready-to-use therapeutic food market will be moderate, and industry players can expect to see sustained growth throughout the forecast period.

Malnutrition is a serious problem impacting humanity today. According to the World Health Organization, nearly 50 million children worldwide are severely malnourished, while almost 500 million are overweight. Around 45% of deaths among children under 5 years are attributed to undernutrition.

Get | Download Sample Copy with Graphs & List of Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-12642

Key Takeaways

MEA to emerge as a hotbed for RUTF manufacturers, owing to high incidence of malnutrition
Drinkable therapeutic foods to enjoy massive popularity due to heightening nutritional supplements demand for infants
UNICEF to remain a frontrunner due to its unwavering commitment to eradicate world hunger
Sales of therapeutic nutritional supplements are likely to survive the COVID-19 pandemic

COVID-19 Impact Insights

The COVID-19 pandemic has amplified the risk of acute malnutrition among the poorest sections of the society. In the face of government-mandated shutdowns, millions of people have become unemployed, especially in the agriculture sector, thus disrupting critical nutrition enhancement programs.

The impact has been especially drastic across the developing and underdeveloped worlds. It is apprehended that severely malnourished children are at a dangerously high risk of contracting the novel coronavirus due to weakened immunity. The same is true for the geriatric population.

Hence, manufacturers are implementing several arrangements to ensure that the availability of ready-to-use therapeutic foods is not hampered. As a result, sales have largely been sustained throughout the course of the pandemic, and is expected to remain so in the future.

Ready-to-use Therapeutic Food Market Players

Market players are actively involved in developing and launching new nutrition enhancing formulations in various forms. In addition, these players are collaborating with governmental and non-governmental agencies to aid in effective distribution of ready-to-use therapeutic foods to the most severely impacted regions.

Prominent players within this landscape include: Nuflower Foods, GC Rieber Compact AS, Valid Nutrition, InnoFaso, Edesia Inc., Nutrivita Foods, Diva Nutritional Products, Insta Products Ltd., Mana Nutritive Aid Product Inc., Meds & Food for Kids Inc, Samil Industrial Co., Tabatchnick Fine Foods Inc., Amul India, and Société de Transformation Alimentaire.

Nuflower Foods, a prominent Indian nutritional foods manufacturer, markets the NutriFEEDO^®ready-to-use therapeutic food paste which is rich in energy and protein to alleviate Severe Acute Malnutrition (SAM). The product is specifically designed for malnourished children, and is easy to digest.

Similarly, GC Rieber Compact AS manufactures the eeZee20^TMwhich is a lipid based nutrient supplement for preventing malnutrition among children aged under 6 months, thus promoting healthy growth by preventing micronutrient deficiencies.

Enhancement of R&D capacities is another approach adopted by RUTF manufacturers. For instance, Nutrivita Foods has a robust research and development department dedicated to the development of effective nutrition enhancing foods. It has a strong ties with Nutriset for this purpose. It also partners with academic organizations to enhance its capabilities.

Ready-to-Use Therapeutic Food Market Key Segment

Type

Solid
Paste
Drinkable Therapeutic Food

End User

UNICEF
WFP
NGOs
Others

Region

North America (U.S & Canada)
Latin America (Brazil, Mexico & Rest of Latin America)
Europe (France, Germany, Spain, U.K, Italy, BENELUX, Nordics, Russia, Poland & Rest of Europe)
Asia Pacific (China, India, Japan, ASEAN, Australia & New Zealand and Rest of APAC)
Middle East & Africa (GCC, North Africa, Tanzania, Ethiopia, Nigeria, Malawi, Kenya, South Africa & Rest of MEA)

Buy This Report@ https://www.futuremarketinsights.com/checkout/12642

Key Questions Answered in the Report

Briefly outline the growth of ready-to-use therapeutic food market.

The global ready-to-use therapeutic food market is anticipated to register a double digit CAGR, crossing the US$ 300 Mn mark by 2020-end.

Which is the most popular ready-to-use therapeutic food?

According to FMI’s analysis, the drinkable foods segments is poised to experience maximum sales. Growth is underpinned by high incidence of infant malnutrition. Also, liquid supplements are easier to digest by young babies.

How will COVID-19 impact the market?

The COVID-19 pandemic has resulted in a major spike in ready-to-use therapeutic food products consumption. High degree of susceptibility to the infection due an already weakened immune system is expected to generate high demand therapeutic foods.

Which region is expected to be the most promising in the future?

The Middle East & Africa is slated to be a revenue hotspot, attributed to a high incidence of poverty and hunger which has ultimately ushered in high levels of malnutrition.

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com

Food Authenticity Market 2022 Size, Development Strategy, Analysis, Opportunity Assessment, Key Players and Trends by Forecast 2030

A new study by Future Market Insights opines food authenticity market to grow at a steady pace through 2030. Adoption will be driven by growing consumer focus on food safety and growing clean label trend. FMI’s new study tracks food authenticity market in 20+ countries for the period 2020-2030.

According to the study, in recent years, access to pure and adulterant free foods has come under significant jeopardy. Widespread prevalence of food adulteration, mislabeling and undisclosed ingredient details have generate a massive furor amongst health conscious consumers as well as healthcare providers.

On an average, approximately 57% of the global population suffers from morbidities inflicted due to consumption of sub-standard and contaminated foodstuffs. Moreover, nearly 1/4^th of the world’s food supply is adulterated annually. Realizing this, countries have taken proactive steps to mitigate the adverse effects of food adulteration.

Get | Download Sample Copy with Graphs & List of Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-12630

Increasing consciousness among consumers has elevated the need for introducing clean-label, organic-based and naturally derived foods. Based on these developments, the global food authenticity market is all set to experience an impressive upsurge in the coming years.

Key Takeaways from FMI’s Food Authenticity Market Report

Global food authenticity market is likely to expand at a noteworthy CAGR in the forthcoming decade
Asia-Pacific to emerge as the fastest expanding region for food authenticity testing, attributed to a large population base
High incidence of meat consumption to provide traction to meat speciation authenticity tests
Economically Motivated Adulterations (EMA) compelling governments to impose tough legislations to keep food adulteration in check
PCR-based tests are expected to retain their popularity due to quick delivery of test results
Processed foods testing is expected to acquire surging popularity due to high demand

COVID-19 Impact Insights

The COVID-19 pandemic presents an exceptional and unprecedented challenge for competent authorities with responsibilities for national food safety control systems. As consumers resort to consuming health and immunity boosting foods, demand for clean-label products is rising exponentially.

While nationwide lockdowns and social distancing measures have limited laboratory testing capacities, it has not fully ceased as chances of food adulteration are maximum during this time period. Unscrupulous traders are prowling the market with the objective of flooding it with adulterated food products.

Thus, leading players have revised growth forecasts to demonstrate that the market is expected to remain afloat albeit at lower projections and reduced revenue margins. Growth is expected to be restored to normal levels in the post-pandemic scenario, once lockdowns are eased following a decline in infection rates.

Leading Food Authenticity Market Players

Some leading players in the global food authenticity market include ALS Ltd., EMSL Analytical Inc, Genetic ID NA Inc., Eurofins Scientific SE, Merieux NutriSciences Corporation, Intertek Group PLC, Microbac Laboratories Inc., SGS SA and Romer Labs to name a few.

The aforementioned players employ a combination of tactics such as product launches, technological advancements, strategic acquisitions and expansion of research facilities in untapped markets.

ALS Ltd., for instance, offers a wide range of testing and analysis with respect to ascertaining food quality. Its food authenticity tests incorporate meat speciation through the ELISA/PCR testing techniques, halal verification and genetically modified foods. It also offers testing for detecting contaminants and allergens.

In May 2016, Intertek established its AgriTech laboratory in Hyderabad, India to perform DNA-based testing of various agricultural products. Simultaneously, the company unveiled its advanced ScanBi DNA technology.

Key Segments

Food Tested

Meat & Meat Products
Dairy & Dairy Products
Processed Foods
Other Food Tested

Target Testing

Meat Speciation
Country of Origin & Ageing
Adulteration
False Labelling

Technology

PCR-Based
Liquid Chromatography-Mass Spectrometry (LC-MS)
Isotope
Immunoassay Based/ELISA
Other Technologies

Region

North America (U.S & Canada)
Latin America (Brazil, Mexico & Rest of Latin America)
Europe (Germany, Italy, France, U.K, Spain, BENELUX & Rest of Europe)
South Asia (India, ASEAN & Rest of South Asia)
East Asia (China, Japan & South Korea)
Middle East & Africa (GCC, South Africa, Israel & Rest of MEA)
Oceania (Australia & New Zealand)

Buy This Report@ https://www.futuremarketinsights.com/checkout/12630

Key Questions Answered in the Report

What are the growth prospects of food authenticity market?

The global food authenticity market is slated to record largely positive growth, experiencing a healthy CAGR throughout 2020-2030. Growth is primarily being underpinned by surging demand for clean-label and adulterant free foods across lucrative markets.

Which is the largest market for food authenticity players?

Asia-Pacific is slated to emerge as the most lucrative revenue generator, attributed to a large population base. Majority of food testing demand is likely to be stimulated from China and India, the world’s most densely populated countries. This is because the prevalence of food adulteration is maximum across these countries.

Who are the leading food authenticity market players?

Presently, the global food authenticity market is interspersed with the presence of the following market players: EMSL Analytical Inc, Genetic ID NA Inc., Eurofins Scientific SE, Merieux NutriSciences Corporation, Intertek Group PLC, Microbac Laboratories Inc., SGS SA and Romer Labs. The aforementioned players employ a combination of tactics such as product launches, technological advancements, strategic acquisitions and expansion of research facilities in untapped markets.

About FMI:

Contact Us:

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com

Customized Premixes Market 2022 Global Development Countries Trends, Size, Industry Reviews with Leading Players

While economic uncertainties due to COVID-19 pandemic is reflected in almost every industrial sector, globally, sales of customized premixes will skyrocket, as the pandemic has highlighted the need for healthy living.

According to Future Market Insights (FMI) global tracker, worldwide revenue of customized premix market will rise 6.37% year over year to US$ 8.8 Bn in 2020. Market players must capitalize on consumers’ ever-increasing focus on health to support healthy lifestyle for employees and shoppers.

Moreover, e-commerce has witnessed a surge as consumers are turning to online channels for grocery shopping – a rise that will be sustained post-COVID-19 pandemic.

Consumption of customized premixes will rise as consumers across the globe are viewing products and brands through a new lens amid the COVID-19 pandemic. Mega consumer trends such as ‘Healthy lifestyle’ are receiving huge spur as purchase decisions are increasingly hovering around nutritional profile of products and services.

Click the link to get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11526

Consumers of all age groups, worldwide, are embracing healthier dietary regimens and putting more emphasis on ingredients, seeking functional ingredients and plant-sourced alternatives. The COVID-19 crisis is redefining customized premix market in real time, triggering long-term fundamental trends within few weeks.

Recent research by Accenture of over 3,000 consumers in 15 countries across five continents has revealed that 64% of individuals are increasingly emphasizing on reducing food wastage, while about 50% are making more health-centric decisions during grocery purchasing and will continue to follow the same going forward.

FMI indicates that these evolving trends will endure post COVID-19 lesson and will remain key long-term priorities among manufacturers as well as consumers.

Customized Premix Market – Competitive Intelligence

The global customized premix market is highly fragmented, characterized by several large-scale as well as medium- and small-scale players. Given rising competition, players are investing in production developments and innovations in order to improve their market position. For instance,

Archer Daniels Midland (ADM) Company has rolled out new assembly of flours, which all-purpose flours, organic flours, and organic premium bread flours, with additional organic milled products.
Karl Fazer has introduced two different bakery products – Fazer Kinuskimarenkileivos and Fazer Suklaamarenkileivos – in an effort to expand its product portfolio to meet requirements in bakery industry.

Key Segment

Ingredient Type

Vitamin Premix
Mineral Premix
Nucleotides Premix
Amino Acids Premix
Enzymes
Coccidiostats
Probiotics
Prebiotics
Multigrain Premix
Omega 3 Fatty Acids
Excipients
Gums
Botanicals
Sweeteners
Flavours
Proteins
Color

Form

Powder
Liquid

Function

Bone Health
Immunity
Digestion
Energy
Heart Health
Weight Management
Vision Health
Brain Health & Memory
Resistance
Others

Application

Food Sector
- Early Life Nutrition/ Baby Food
- Medical Nutrition
- Sports Nutrition
- Energy Drinks
- Milk and Milk products
- Bakery and Confectionery Products
- Cereals & Snacks
- Oils and fats
- Staple foods (Flour, Salt and Rice)
Dietary Supplements
Pharma OTC Drugs
Pet Food

Product Type

Premix blends/ Direct-to-consumer Solutions
Drum-to-hopper Formulations

Regional Outlook

North America (US, and Canada)
Latin America (Brazil, and Mexico)
Europe (Germany, UK, Russia, France, and Italy)
South Asia (India, Indonesia, and Thailand)
East Asia (China, Japan, and South Korea)
Oceania (Australia and New Zealand)
Middle East & Africa (MEA) (Turkey, GCC Countries, and South Africa)

Buy This Report@ https://www.futuremarketinsights.com/checkout/11526

Key Questions Answered in the Report

How the market for customized premix is expected to shape up in coming ten years?

The global customized premix market size will value around US$ 17.9 Bn in 2030. Market revenue pool will expand 6.37% year over year in 2020.

Which is the largest market for customized premixes?

North America and Europe represent the largest markets for customized premixes, globally, given heightening health concerns as well as strict regulatory norms regarding food fortification.

How the competition is structured in global customized premix market?

The global customized premix market is highly fragmented with presence of various leading and emerging players including, Archer Daniel Midland Company, AQC Chem Lab (P) Ltd, and Barentz International B.V..

Which product type will remain high in demand in global customized premix market?

Among various product types, demand for premix blends will remain high over decade ahead in global customized premix market. However, market players are also tapping into direct-to-consumer solutions to ensure relevant returns.

Which application will remain highly profitable for players in global customized premix market?

Market players are reaping substantial revenue from food sector. Under the application category, usage of customized premixes will remain prominent in bakery and confectionery products and cereals & snacks.

About FMI:

Contact Us:

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com

Vegan Protein Powder Market Insights Report 2022 with COVID-19 Pandemic Analysis & Future Growth Analysis by 2030

The global demand for vegan protein powders has risen strongly in 2020, even though the coronavirus pandemic has impacted the market marginally owing to lockdown measures. The prospects of the industry are positive through 2027 as per a recent study by Future Market Insights (FMI). The report has indicated that the market will witness promising growth in the near future, with demand for nutraceutical and supplements during the pandemic.

In a report by FMI, it is stated that vegan protein powders based out of natural sources such as soy and pea will remain highly sought after for applications in the food and beverage processing sector, and also in health and wellness products. Direct sales approaches have proven more fruitful, with consumers choosing to use company websites for better deals on purchases.

The vegan protein powder market displays strong growth on account of health concerns over meat consumption and growing awareness about the ethics of animal farming. Also, the wider range of product flavours and investments towards product functionality in muscle repair, and maintenance for fitness enthusiasts will aid the market for the foreseeable future.

While sales of vegan protein powders are gaining ground rapidly, consumer preference for animal-based products, lack of clean label certifications, and poor consumer awareness in developing countries are obstacles for players in the industry.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12549

The report by FMI offers an exhaustive overview, covering critical market dynamics. Some of the major takeaways from the study include:

Market is estimated at 4.7 billion in 2020, with demand rising steadily during the coronavirus pandemic
Soy-based vegan protein powders remain highly sought after owing to higher product awareness and visibility
Food processing applications of vegan protein powder witnessing strong demand owing to demand for functional foods and beverages
Sales in the North America are critical to market development, owing to extensive applications in sports nutrition applications. However, South Asia & Oceania is displaying lucrative growth opportunities for market players with a vast vegan and vegetarian population base

Covid-19 Impact on Vegan Protein Powder Market

The demand for vegan protein powders is expected to be marginally impacted by the coronavirus pandemic. The industry is likely to face minor supply chain interruptions during this period, owing to lockdown restrictions affecting transport and logistics.

On the other hand, the demand for functional foods and nutraceuticals during this period will positively affect the market. Online sales are likely to witness an increase, even as small retailers are forced to temporarily shut operations.

On the other hand, the effects of the pandemic on the agriculture sector will have an important effect on market development, as viral transmission among farm laborers remain a concern.

Who is Winning?

In the study, FMI has analyzed the various business strategies being used by major companies in the vegan protein powder market. Leading market players are emphasizing widening their product portfolio with product development products in addition to capacity expansion and geographic expansion through industry collaboration for stronger distribution networks.

Some of the key players in the market include Archer Daniels Midland Company, AGT Food and Ingredients, Cargill Inc., A&B Ingredients, Ingredion Inc., The Scoular Company, Green Lab LLC, Kerry Group, and Roquette Freres among others.

Vegan Protein Powder market Segmentation

Source

Soy
Wheat
Pea
Others

Flavors

Unflavored
Chocolate
Vanilla
Strawberry
Blueberry
Others

Application

Food Processing
Nutritional Products
Animal Feed
Household (Retail)
Others

Distribution Channel

Direct Sales
Hypermarkets/Supermarkets
Specialty Stores
Pharmacy & Drug Stores
Online Stores
Others

Regional Outlook

North America (U.S., Canada)
Latin America (Brazil, Mexico, Peru, Argentina, Chile, Rest of LATAM)
Europe (EU-4, U.K., BENELUX, Nordics, Eastern Europe, Rest of Europe)
East Asia (China, Japan, South Korea)
South Asia & Oceania (India, Thailand, Indonesia, Malaysia, Australia, Rest of South Asia & Oceania)
Middle East & Africa (GCC Countries, Northern Africa, South Africa, Turkey, Rest of MEA)

Buy This Report@ https://www.futuremarketinsights.com/checkout/12549

Key Questions Answered in the Report

What is the size of the vegan protein powder market?

The global vegan protein powder market is estimated to have reached a value of US$ 4.4 billion in 2020. The industry will rise at a 6.6% CAGR between 2019 and 2027.

Which is the largest market for vegan protein powder?

North America is the leading market for vegan protein powders. Growing levels of health consciousness among consumers and the expansion of vegan populations aid market growth.

Which are the top companies in vegan protein powder market?

Some of the leading companies operating in the market are Archer Daniels Midland Company, AGT Food and Ingredients, Cargill Inc., A&B Ingredients, Ingredion Inc., The Scoular Company, and The Kerry Group among others.

What are the applications of vegan protein powder?

Vegan protein powders are finding use in the food and beverages sector, and is popular among people suffering from allergies. Vegan protein powders are also increasingly playing roles in animal feedstock formulations to keep up with consumer biases.

From what materials are vegan protein powders sourced?

Vegan protein powders are extracted from three major plant sources. These include soy, wheat, and peas. Of these, soy protein powders are highly popular and are estimated to account for more than 50% of the overall market share by 2027.

Will South Asia & Oceania exhibit higher demand for vegan protein powder?

Countries in South Asia and Oceania are potentially lucrative markets for vegan protein powder manufacturers. The rise in health awareness coupled with a substantial vegan and vegetarian population in the region drives growth.

About FMI:

Contact Us:

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com